Trial Comparing Two Carboplatin Doses in Groups C and D Intraocular Retinoblastoma
Status:
Unknown status
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether an increase in the dose of carboplatin in
treatment of advanced intraocular (group C and D) retinoblastoma helps in avoiding
radiotherapy and improves the rate of globe salvage.
Phase:
N/A
Details
Lead Sponsor:
All India Institute of Medical Sciences, New Delhi
Collaborator:
Council of Scientific and Industrial Research, India